AI Is Redesigning Pharma and MedTech Operating Models: Is Yours Keeping Up?

OVERVIEW

AI initiatives are everywhere across pharma and medical devices: from discovery and trial optimization to connected products and commercial analytics.

Competitive advantage isn’t coming from pilots: it’s coming from organizations that have redesigned how they operate around data and intelligence.

This dinner will explore questions leaders are quietly wrestling with:

• Has AI changed your decision-making speed - or just your slide decks?
• Is your data architecture enabling cross-functional intelligence, or reinforcing silos?
• What are the challenges to implement AI within your functional area and what measures have worked well to overcome these barriers? Data Quality & availability, Regulatory & Compliance, Trust, Governance, any other?
• What governance and KPIs are established to measure & monitor the success of AI investment?
• Can your regulatory and quality frameworks support adaptive systems?
• Are you building capabilities internally - or creating long-term vendor dependency?
• Where is AI actually shifting economics in your value chain?

This is a candid conversation among peers about what’s working, what’s stalling, and what needs to change structurally.

Because in pharma and medtech, AI won’t just improve processes: it will determine who sets the pace for the next decade.